Similar articles

• Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

  Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group. Munteanu M, et al. Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17. Aliment Pharmacol Ther. 2018. PMID: 30334263 Free PMC article.
• Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.

  Wong CR, Njei B, Nguyen MH, Nguyen A, Lim JK. Wong CR, et al. Aliment Pharmacol Ther. 2017 Dec;46(11-12):1061-1069. doi: 10.1111/apt.14342. Epub 2017 Sep 28. Aliment Pharmacol Ther. 2017. PMID: 28960360
• Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.

  Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. Marot A, et al. PLoS One. 2017 Oct 27;12(10):e0186715. doi: 10.1371/journal.pone.0186715. eCollection 2017. PLoS One. 2017. PMID: 29077714 Free PMC article.
• [Research advances in nonalcoholic fatty liver disease and alcoholic liver disease in 2016].

  Chen YS, Wang BY, Li YM. Chen YS, et al. Zhonghua Gan Zang Bing Za Zhi. 2017 Mar 20;25(3):181-186. doi: 10.3760/cma.j.issn.1007-3418.2017.03.005. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28482404 Review. Chinese.
• Non-alcoholic fatty liver disease: diagnosis and investigation.

  Nascimbeni F, Loria P, Ratziu V. Nascimbeni F, et al. Dig Dis. 2014;32(5):586-96. doi: 10.1159/000360510. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034292 Review.